Investors

SEC Filings

Form DEF 14A
BRAINSTORM CELL THERAPEUTICS INC. filed this Form DEF 14A on 10/10/2018
Document Outline
Entire Document (778.1 KB)
Subdocument 1 - DEF 14A - DEF 14A
Page 1 - UNITED STATES
Page 2 - BRAINSTORM CELL THERAPEUTICS INC.
Page 3 - BRAINSTORM CELL THERAPEUTICS INC.
Page 4 - BRAINSTORM CELL THERAPEUTICS INC.
Page 5 - Voting Instructions
Page 6 - Revocability of Proxies
Page 7 - N/A
Page 8 - PROPOSAL NO. 1
Page 9 - Dr. Anthony Polverino joined the Company on February 5, 2018 as a director. Dr. Polverino `is curren
Page 10 - Malcolm Taub joined the Company in March 2009 as a director. Since October 2010, Mr. Taub has been a
Page 11 - Qualifications of Directors
Page 12 - N/A
Page 13 - The Board of Directors recommends a vote FOR the approval, on a non-binding advisory basis, of the c
Page 14 - PROPOSAL NO. 3
Page 15 - PROPOSAL NO. 4
Page 16 - New Plan Benefits
Page 17 - Summary of the 2014 Stock Incentive Plan (as amended)
Page 18 - Descriptions of Awards
Page 19 - Limitation on Repricing of Options; Other Limitations. With respect to options, unless such action i
Page 20 - Eligibility to Receive Awards
Page 21 - Amendment of Awards. Except as otherwise provided under the 2014 U.S. Plan with respect to repricing
Page 22 - Provisions Applicable to Restricted Stock. Upon the occurrence of a reorganization event other than
Page 23 - Effective Date and Term of 2014 U.S. Plan
Page 24 - Summary of the 2014 Global Share Option Plan (as amended)
Page 25 - Merger; Acquisition; Reorganization. The 2014 Global Plan provides that in the event of a merger, ac
Page 26 - Israeli Appendix and Tax Matters
Page 27 - PROPOSAL NO. 5
Page 28 - CORPORATE GOVERNANCE AND BOARD MATTERS
Page 29 - Board Meetings
Page 30 - Stockholder Nominations
Page 31 - Family Relationships
Page 32 - Uri Yablonka joined the Company on June 6, 2014 as Chief Operating Officer and as a member of the Bo
Page 33 - Executive Employment Agreements
Page 34 - N/A
Page 35 - N/A
Page 36 - Terms of Option Awards
Page 37 - Stock Incentive Plans
Page 38 - N/A
Page 39 - Certain Relationships and Related Transactions
Page 40 - Research and License Agreement with Ramot
Page 41 - Independent Registered Public Accounting Firm
Page 42 - Pre-approval Policies
Page 43 - Section 16(a) Beneficial Ownership Reporting Compliance
Page 44 - Annual Report on Form 10-K
Page 45 - BRAINSTORM CELL THERAPEUTICS INC.
Page 46 - BRAINSTORM CELL THERAPEUTICS INC.
Page 47 - N/A
Page 48 - N/A